Natco Pharma Q4 PAT plunges to Rs 120 crore
The company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25 per equity share for 2018-19, Natco Pharma said.
New Delhi: Natco Pharma Monday reported a steep decline in consolidated profit after tax at Rs 120.4 crore for the quarter ended March 31, 2019. The company posted a profit after tax of Rs 299.7 crore for the year-ago period, Natco Pharma said in a filing to BSE.
Total revenue stood at Rs 486.7 crore for the quarter under review. It was Rs 787.9 crore for the same period a year ago.
Read Also: Setback: Delhi HC restricts Natco Pharma from manufacturing cancer drug Ceritinib
The company's profit after tax for 2018-19 was at Rs 642.4 crore as against Rs 695.2 crore in the previous year.
Total revenue for the last fiscal stood at Rs 2,224.7 crore. It was Rs 2,242.4 crore in 2017-18.
The company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25 per equity share for 2018-19, Natco Pharma said.
Founded in 1981, the company is based in Hyderabad. The roots of the company go back to the founding of NATCO (Acronym for National Trading Company) Pharmaceutical Division in Kothur, Telangana.
Read Also: Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets
Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd